Translocator protein (18 kDa) regulates the microglial phenotype in Parkinson’s disease through P47
Open Access
- 1 April 2022
- journal article
- research article
- Published by Taylor & Francis in Bioengineered
- Vol. 13 (4) , 11062-11072
Abstract
Numerous studies have suggested that the phenotypic transformation of microglia plays a role in the pathogenesis of Parkinson’s disease (PD). Translocator protein (TSPO) is an 18 kDa translocator membrane protein that acts as a marker of neuroinflammation and suppresses neuroinflammation; however, its underlying mechanism remains unclear. Although TSPO ligands were found to be protective in several neurodegenerative paradigms, few studies have evaluated their effects on microglial polarization, and underlying mechanisms need to be explored. In the present study, we examined the effects of TSPO and PK11195, a TSPO ligand, on lipopolysaccharide (LPS)+interferon (IFN)-γ-induced inflammatory factors and oxidative stress in microglia using enzyme-linked immunosorbent assay. The effect of TSPO and PK11195 on LPS+IFN-γ-induced microglial cell apoptosis was examined using immunofluorescence (IF), flow cytometry, and western blotting. The interaction between TSPO and P47 was investigated using IF and co-immunoprecipitation analysis. In vivo experiments confirmed the influence of TSPO and its ligand on motility, a-Syn, and dopaminergic neuronal damage. Our findings indicate that TSPO may regulate the microglial phenotype in PD via P47, suggesting a potential role in anti-PD therapy. Graphical abstractKeywords
Funding Information
- National Natural Science Foundation of China (81803507)
This publication has 43 references indexed in Scilit:
- A TSPO ligand attenuates brain injury after intracerebral hemorrhageThe FASEB Journal, 2017
- Epidemiology of Parkinson’s diseaseJournal of Neural Transmission, 2017
- Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson’s disease and Alzheimer’s diseaseProgress in Neurobiology, 2016
- Role of Microglia in Neurological Disorders and Their Potentials as a Therapeutic TargetMolecular Neurobiology, 2016
- TSPO Finds NOX2 in Microglia for Redox HomeostasisTrends in Pharmacological Sciences, 2016
- Different pathways of macrophage activation and polarizationPostępy Higieny I Medycyny Doświadczalnej, 2015
- Role of Translocator Protein Density, a Marker of Neuroinflammation, in the Brain During Major Depressive EpisodesJAMA Psychiatry, 2015
- Differential Roles of M1 and M2 Microglia in Neurodegenerative DiseasesMolecular Neurobiology, 2015
- Ligand for Translocator Protein Reverses Pathology in a Mouse Model of Alzheimer's DiseaseJournal of Neuroscience, 2013
- Translocator protein (18 kDa)/peripheral benzodiazepine receptor specific ligands induce microglia functions consistent with an activated stateGlia, 2010